Drug Approvals

FDA approves Vyloy for HER2-negative gastric and GEJ cancer

FDA · HER2-negative gastric cancer · 5 min

AbbVie closes $8.7B Cerevel deal as neuroscience pipeline expands

U.S. Federal Trade Commission · immunology · 5 min

Lenacapavir posts 100% HIV prevention in PURPOSE 1

FDA · HIV · 8 min

J&J reports positive Phase 3 Tremfya data in ulcerative colitis

CHMP · ulcerative colitis · 7 min

FDA approves Dupixent for COPD with eosinophilic phenotype

FDA · chronic obstructive pulmonary disease · 6 min

GSK Blenrep wins FDA approval in relapsed multiple myeloma

FDA · blood cancer · 6 min

FDA Approves Vertex’s First-in-Class Non-Opioid Pain Drug Journavx

FDA · moderate-to-severe acute pain · 8 min

FDA approves Keytruda for adjuvant NSCLC treatment, expanding Merck’s lung cancer label

FDA · lung cancer · 6 min

Novo Nordisk CagriSema Phase 3 Results: Obesity Catalyst Update

EMA · obesity · 7 min

FDA approves Merck’s Keytruda for adjuvant NSCLC treatment

FDA · lung cancer · 8 min

Eli Lilly's donanemab wins FDA approval for early Alzheimer's disease

FDA · Alzheimer's disease · 6 min

FDA approves Keytruda for adjuvant NSCLC, a Merck catalyst

FDA · lung cancer · 7 min